DeTection Inc. is pioneering fully autonomous AI robotic procedures — medical, dental, cosmetic, ophthalmology, dermatology, and veterinary — powered by hybrid classical and quantum algorithms. No human operator. No guesswork.
DeTection Inc. (Delaware, 2022) — operating as 6r.ai and MedsApp.ai — develops AI systems that fully replace human operators in physical procedures. Our platform combines classical AI algorithms, quantum computing, robotics, and real-time matter detection to deliver precise, autonomous outcomes at scale.
Autonomous robotic systems for medical, dental, cosmetic, ophthalmology, dermatology, and veterinary procedures. Patent-pending methods enable full procedure execution without any human operator intervention.
Application Pending · USPTO 19/532,226 (Not Yet Published)The Universal Multipurpose Matter Detection Apparatus identifies pathogens, microbes, and abnormal cells in real time. The core sensing technology behind autonomous medical and industrial procedures.
Published · USPTO 18/141,374 · View on Google Patents ↗AI-powered automation for veterinarians, mortuaries, and testing facilities. The 6R framework — Revenue, Reliability, Recognizing, Results, Respect, Rethink — drives full operational automation across industries.
Active · Tampa, FLThe MedsApp.ai patent system enables fully autonomous physical procedures using one of three proprietary control methods. A robotic apparatus executes each procedure while a real-time data pool is continuously compared to archived patient data — no human operator issues commands at any stage.
A pre-planned digital twin of the patient procedure guides the robot step-by-step. Every action is mapped in advance using patient intake data, CAD models, and 3D/4D Cartesian coordinate grids (x, y, z axes — extended to k, l, d axes with quantum computing).
The robot "bounces" between two data pools in real time — the live patient feed and an archived pool of prior patient outcomes. An Effect Differential score is computed continuously to determine the optimal next action.
Physical reference markers are placed on or around the patient to establish a precise geometric coordinate system. The robot uses these markers to navigate and execute procedures with sub-millimeter accuracy.
MedsApp.ai does not rely on classical computing alone. The procedure-execution subsystem integrates quantum computing at the decision layer — using qubits, superposition, and entanglement to process multi-dimensional patient data at speeds impossible with conventional hardware.
Quantum lasers and quantum key distribution (QKD) secure all data streams. The k, l, d quantum axes extend the standard Cartesian x, y, z axes into a fourth-dimensional procedure space, enabling precision unavailable in conventional robotics.
Superposition-based processing of multiple patient data states simultaneously
Correlated qubit pairs for instantaneous state comparison across the system
High-precision targeting and matter detection at the quantum energy level
Quantum key distribution secures all patient data and command channels
Quantum Processing Layer — Procedure Execution Subsystem
The MedsApp.ai system handles the full patient journey — intake, assessment, procedure planning, real-time execution, and post-procedure logging — without human operator involvement at any stage.
The system autonomously collects patient history, symptoms, and physiological data, then computes a Procedure Demand Score from 1–100. A score of 92.6, for example, indicates a high-confidence demand for a specific procedure (e.g., gallbladder removal). The system proceeds only when thresholds are met.
The Universal Multipurpose Matter Detection Apparatus (UMMDA) identifies pathogens, microbes, viruses, abnormal cells, and target tissues in real time. Integrated across all procedure modes, the UMMDA feeds detection data directly into the autonomous decision loop — including biosurfactant misting for surface preparation.
Mobile platforms include onboard 3D printers capable of fabricating replacement body parts, implants, or surgical materials in situ. The AI Med Bus — a fully autonomous mobile vehicle — brings the complete procedure system to remote or underserved locations, enabling procedures outside traditional medical facilities.
Every procedure is monitored by a patent-claimed autonomous safety module that continuously evaluates patient and system status. If a critical threshold is reached — or the evaluation window expires — the module immediately triggers an emergency alert and halts the procedure.
The safety module operates independently of the procedure controller, ensuring failsafe behavior even in the event of primary system failure. No human override is required; the system is designed to protect the patient autonomously.
DeTection Inc. holds two patent families with applications filed in the United States and internationally via the Patent Cooperation Treaty. Both families have received granted patents.
Priority chain spanning 13 provisional applications from March 17, 2025 through January 13, 2026. Covers all three autonomous procedure control methods, quantum computing integration, UMMDA detection, patient intake, safety module, mobile platforms, and roaming internal micro-robots. 20 claims.
The foundational matter detection patent covering the UMMDA apparatus. Enables real-time identification of pathogens, microbes, and target matter across medical, industrial, and environmental applications. Published November 23, 2023. Forms the sensing layer for the MedsApp.ai robotic procedure system.
Watch DeTection Inc.'s autonomous detection systems and AI-powered procedures in action.
Overview of the 6r.ai platform and MedsApp.ai robotic procedure technology.
UMMDA in action — real-time pathogen and abnormal cell detection system.
6r.ai applies DeTection Inc.'s AI and robotics technology to automate veterinary practices, mortuaries, and testing facilities. The 6R framework encodes the six outcomes every automated operation must deliver.
Automation generates new revenue streams by expanding throughput and enabling procedures at scale without proportional staffing costs.
AI-directed procedures deliver consistent, repeatable results — removing human error and variability from every operation.
The UMMDA and quantum detection layer recognize pathogens, anomalies, and target matter in real time with precision no human can match.
Fully autonomous procedures, from intake through completion, produce measurable, auditable results logged to the patient record.
Autonomous systems handle sensitive procedures — mortuary, veterinary, cosmetic — with consistency and dignity that human-variable environments cannot guarantee.
The entire premise of human-dependent physical procedures is rethought from first principles — autonomy, not augmentation, is the goal.
Full automation of veterinary procedures including diagnostics, surgery, and post-operative monitoring — expanding access to care without specialist headcount.
AI-driven sample processing, UMMDA pathogen detection, and automated reporting for high-throughput testing environments.
Autonomous handling, processing, and documentation at mortuary facilities — consistent, dignified, and fully logged without manual intervention.
Keith founded DeTection Inc. in Delaware in 2022 with the mission of full automation of physical procedures through AI and robotics. He leads all technology strategy, intellectual property development, and the build-out of the 6r.ai and MedsApp.ai platforms. The company is headquartered in Tampa, Florida.
DeTection Inc.'s mascot and symbolic representative of the fully autonomous future. Robot Rex embodies the company's vision: technology that operates independently, precisely, and tirelessly — without human intervention.
The full autonomous medical robotics platform — patent applications, procedure overview, and technology deep-dive — lives at MedsApp.ai. Visit to learn more about how the system performs autonomous procedures across medical, dental, cosmetic, ophthalmology, dermatology, and veterinary fields.
Visit MedsApp.ai →